Search results
We are a focused biopharma company with strong momentum and big ambitions, to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive.
- Locations
Locations - Home | GSK
- Why Invest in GSK
Why Invest in GSK - Home | GSK
- Fresh Insights Could Finally Help US Tackle RSV
At GSK, we have decades of scientific leadership in...
- History and Heritage
The GSK of today. GSK plc underwent a transformation in...
- Press Releases
GSK plc (LSE/NYSE: GSK) has today announced that Dr Jeannie...
- The Pain, Risks, and First Symptoms of Shingles Every Adult Should Know
The Pain, Risks, and First Symptoms of Shingles Every Adult...
- Technologies
Technologies - Home | GSK
- Speeches and Presentations
Getting ahead of Oncology with GSK management. Join GSK...
- Locations
GSK is the tenth largest pharmaceutical company and #294 on the 2022 Fortune Global 500, ranked behind other pharmaceutical companies China Resources, Sinopharm, Johnson & Johnson, Pfizer, Roche, AbbVie, Novartis, Bayer, and Merck Sharp & Dohme.
Find the latest GSK plc (GSK) stock quote, history, news and other vital information to help you with your stock trading and investing.
People also ask
Who is GSK?
Is GSK a good pharmaceutical company?
What does GSK stand for?
Where is GSK located?
GSK. This is our US website, intended for US audiences only. Other market sites can be reached by visiting our location selector. © 2001-2024 GSK plc. All rights reserved. Trade marks are owned by or licensed to the GSK group of companies. GSK plc. Registered in England and Wales No. 3888792.
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together.
Investors | GSK. 2024 First quarter announcement. We announced our first quarter 2024 results on Wednesday 1 May. Access our first quarter results and latest Annual Report below. Q1 2024 results Annual Report 2023 (PDF - 8.3MB) We’re confident in our future.
Get the latest GSK plc (GSK) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.